Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia

Israel Medical Association Journal

Volumn 10, Issue 5, 2008, Pages 335-338

  Pinsk, Vered ^a   Levy, Jacov ^a   Moser, Asher ^a   Yerushalmi, Baruch ^a   Kapelushnik, Joseph ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Anemia; Intravenous iron sucrose; Iron deficiency

Indexed keywords

FERRIC HYDROXIDE SUCROSE; FERRITIN; HEMOGLOBIN; IRON;

ADOLESCENT; ARTICLE; BIOCHEMISTRY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXTRAVASATION; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HYPOTENSION; INFANT; IRON DEFICIENCY ANEMIA; IRON OVERSATURATION; MALABSORPTION; MALE; METABOLIC DISORDER; PAIN; PROSPECTIVE STUDY; SIDE EFFECT; VOMITING;

ADOLESCENT; ANEMIA, IRON-DEFICIENCY; CHILD; CHILD, PRESCHOOL; FEMALE; FERRIC COMPOUNDS; FERRITINS; HEMATINICS; HEMOGLOBINS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 46149105437     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Demaeyer E. Preventing and Controlling Iron Deficiencv Anemia through Primary Health Care: A Guide for Health Administrators and Program Managers. Switzerland: World Health Organization, 1989:27.
2. Bilenko N, Yehiel M, Inbar Y, Gazala E. The association between anemia in infants and maternal knowledge and adherence with iron supplementation in southein Israel. IMAJ 2007;9:521-4.
3. ACC/SCN, IFPRI. Fourth report on the world nutrition situation. SCC/SCN Geneva; 2000:21-7.
4. Meyerovitch J, Sherf M, Antebi F, et al. The incidence of anemia in an Israeli population: a population analysis for anemia in 34512 Israeli infants aged 9 to 18 months. Pediatrics 2006;118(4) e1055-60.
5. American Academy of Pediatric Committee on Nutrition. The use of whole cow's milk in infancy. Pediatrics 1992;89:1105-9.
6. Bailie GR, Johnson CA, Mason NA. Parenteral iron use in the managernent of anemia in end-stage renal disease patients. Am J Kidney Dis 2000;35:1-12.
7. Shimada A. Adverse reactions to total-dose infusion of iron dextran. Clin Pharm 1982;1:248-9.
8. Sunder-Plassmann G, Horl WH. Safety aspects of parenteral iron in patients with end-stage renal disease. Drug Saf 1997;17:241-50
9. Rosenlof K, Kivivuori SM, Gronhagen-Riska C, Teppo AM, Slimes MA. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrol 1995;43:249-55.
10. Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 1999;33:464-70.
11. Van Wyck DB, Cavallo G, Spinowitz BS, et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis 2000;36:88-97.
12. Notebaert E, Chauny JM, Albert M, Fortier S, Leblanc N, Williamson DR. Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis. Transfusion 2007;47:1905-18.
13. Morgan HE, Holt RC, Jones CA, Judd BA. Intravenous iron treatment in pediatric chronic kidney disease patients not on erythropoietin. Pediatr Nephrol 2007;22:1963-5.
14. Kosch M, Bahner U, Bettger H, Matzkies F, Teschner M, Schaefer RM. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. Nephrol Dial Transplant 2001;16:1239-44.
15. Silverberg DS, Blum M, Agbaria Z, et al. Intravenous iron for the treatment of predialysis anemia. Kidney Int Suppl 1999;69:S79-85.
16. al Momen AK, al Meshari A, al Nuaim L, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;69:121-4.
17. Lanzkowsky P. Iron deficiency anemia. In: Pediatric Hematology-Oncology. 3rd edn. San Diego: Academic Press, 2000:48.
18. Table 715-6. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th edn. Philadelphia: WB Saunders, 2007:2944.
19. Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis 2001;38:988-91.
20. Hershko C, Hoffbrandt AV, Keret D, et al. Role ol autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Hemotologica 2005;90:585-95.
21. Mamula P, Piccoll DA, Peck SN, Markowitz JE, Baldassano RN. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;34:286-90.
22. Berniere J, Dehullu JP, Gall O, Murat I. Intravenous iron in the treatment ot post operative anemia in surgery of the spine in infants and adolescents. Rev Chir Orthp Reperat Appar Mot 1998;84:319-22.
23. Akarsu S, Taskin E, Yilmaz E, Kilic M, Aygun AD. Treatment of iron deficiency anemia with intravenous iron preparatiovs. Acta Hematol 2006;116:51-7.
24. Pollak A, Hayde M, Hayn M, et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature Infants. Pediatrics 2001;107:78-85.
25. Koorts AM, Viljoen M. Ferritin and ferritin isoforms. I: Structure-function relationship, synthesis, digradation and secretion. Arch Physiol Biochem 2007;113:30-54.